About Index Trending news
Analyze
Pricing
Repligen

Repligen

Work at Repligen? Add yourself to this profile

Repligen

Nearly all therapeutic monoclonal antibodies (mAbs) on the market or in development are produced using bioprocessing products manufactured by Repligen
Edit Profile
More info

Elsewhere

Companies in the same industry

JumpStartInc JumpStartInc Complete Genomics Complete Genomics BioSurplus BioSurplus Hygiena LLC Hygiena LLC Recombinetics Recombinetics BiogeniQ BiogeniQ Malin Corporation plc Malin Corporation plc Canopy Biosciences Canopy Biosciences clustermarket clustermarket Invenra Invenra

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 1
Add info
Latest funding
Venture capital
$4,000,000
Employees

Team size

50+
Locations
Unknown
Help us complete this profile
The Motley Fool

Read This Before You Sell Repligen Corporation Stock

Repligen
Repligen
The Motley Fool

Repligen Corporation Jumped 14.6% in February -- Here's Why

Repligen
Repligen
The Motley Fool

Why Repligen Corporation Shares Are Falling --

Repligen
Repligen